Discussion: 'Novel clomiphene protocol in polycystic ovarian syndrome' by Hurst et al.
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Hurst BS, Hickman JM, Matthews ML, Usadi RS, Marshburn PB. Novel clomiphene "stair-step" protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obstet Gynecol 2009;200:510.e1-510.e4.
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
G Wright
GW
Bates
Stacy
S
Shomento
Katherine
K
McKnight
Hope M
HM
McLean
D000858:Anovulation / Q000188:drug therapy* / Q000191:economics / Q000209:etiology*; D002996:Clomiphene / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D009765:Obesity / Q000628:therapy; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000191:economics; D011247:Pregnancy; D016896:Treatment Outcome
D005300:Fertility Agents, Female; D002996:Clomiphene